NGS EQA 2025

1. different EQA subschemes for mutation analyses: 

   • A. targeted multi marker NGS panels basic: therapy-relevant genes across entities 
   • B. NSCLC- specific NGS panels:
     mandatory gene list defined in cooperation with the “National Network Genomic Medicine (nNGM) Lung Cancer”
   • C. NGS-Panels (Coverage > 1 MB):
     mandatory gene list in cooperation with the  “German Network for Personalized Medicine (DNPM)”
      

2. different EQA subschemes for fusions analyses:

   • A. NSCLC- specific NGS panels:
     mandatory fusion list defined in cooperation with the  “National Network Genomic Medicine (nNGM) Lung Cancer”
   • B. NGS-RNA panels for fusions:
     therapy-relevant fusions across entities 

All subschemes can be booked independently. 
Registration for mutation analyses subschemes will start in January 2025. 

Additional information and updates will follow soon in our Newsletter, EQA program and on our homepage. 

In case of questions please contact:
Dr. rer. nat. Katharina Ilm (ilm@quip.eu; +49 30 921 0717 25)
Celina Lindner (lindner@quip.eu; +49 30 921 0717 27)
Jana Knauß (knauss@quip.eu; +49 30 921 0717 28)